Justlina-M Forte Tablet

The synergistic action of these agents helps achieve better glycemic control by targeting multiple pathophysiological defects associated with type 2 diabetes. Justlina-M Forte is prescribed as an adjunct to diet and exercise to improve glycemic parameters such as fasting blood glucose and HbA1c levels. It is particularly beneficial for patients inadequately controlled on metformin monotherapy or those requiring combination therapy to minimize the risk of hypoglycemia and weight gain.

Dosage adjustments may be necessary in patients with renal or hepatic impairment. Common adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, while Linagliptin is generally well tolerated. Regular monitoring of blood glucose and renal function is recommended during therapy to ensure safety and efficacy.